Melanoma: open trials in Slovenia

10 open trials have a site in Slovenia. Registry data; only the trial team decides who can take part.

NCT07761871
Exercise and Nutritional Intervention in Patients With Melanoma Receiving Immunotherapy
Trial Treatment · Institute of Oncology Ljubljana
Institute of Oncology Ljubljana, Ljubljana
Registry updated 2026-10-07
NCT05727904
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Trial Treatment · Phase 3 · Iovance Biotherapeutics, Inc.
Institute of Oncology Ljubljana, Ljubljana
Registry updated 2026-09-24
NCT07015190
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Trial Treatment · Phase 3 · IDEAYA Biosciences
Institute of Oncology Ljubljana, Ljubljana
Registry updated 2026-05-06
2023-510017-26-00
A Double-Blind, Randomized, Three-arm, Active-Controlled, Parallel-Group, Phase 1 Study Evaluating Pharmacokinetic Similarity of Three Formulations of Pembrolizumab (CT-P51, EU-approved Keytruda, and US-licensed Keytruda) as Adjuvant Therapy in Patients with Completely Resected Stage IIB, IIC, and III Melanoma
Trial Treatment · Phase 1 · Celltrion Inc.
Institute of Oncology Ljubljana, Ljubljana
Registry updated 2026-04-20
NCT07422779
Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia
Trial Treatment · Institute of Oncology Ljubljana
Institute of Oncology Ljubljana, Ljubljana
Registry updated 2026-02-20
NCT06388252
Electrochemotherapy Changes in Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Melanoma Patients
Trial Treatment · Institute of Oncology Ljubljana
Institute of Oncology Ljubljana, Ljubljana
Registry updated 2026-02-19
NCT07404605
Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma
Trial Treatment · Institute of Oncology Ljubljana
Institute of Oncology Ljubljana, Ljubljana
Registry updated 2026-02-19
NCT07407166
Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers
Trial Treatment · Institute of Oncology Ljubljana
Institute of Oncology Ljubljana, Ljubljana
Registry updated 2026-02-17
NCT03860883
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Trial Treatment · Melanoma and Skin Cancer Trials Limited
Institute of Oncology Ljubljana, Ljubljana
Registry updated 2024-11-27
NCT05878977
Biomarkers in Immunotherapy of Melanoma
Trial Treatment · Institute of Oncology Ljubljana
Institute of Oncology Ljubljana, Ljubljana
Registry updated 2024-10-18

All Melanoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error